Rubicon Organics Inc. (OTCQX: ROMJF) (TSXV:ROMJ) achieved record net revenue for Q1 2023 of CA$8.8 million ($6.5 million), a 71% increase from Q1 2022, primarily driven by the expansion of 1964 Supply Co, having a full year of sales in all key markets, continued range expansion, and a new hero strain with Comatose.

Q1 2023 Financial Highlights

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.